메뉴 건너뛰기




Volumn 24, Issue 5, 2010, Pages 295-299

Serum KL-6 levels in lung cancer patients with or without interstitial lung disease

Author keywords

Interstitial lung disease; KL 6; Lung cancer

Indexed keywords

GLYCOPROTEIN; KL 6; MUCIN; UNCLASSIFIED DRUG;

EID: 77957283021     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20404     Document Type: Article
Times cited : (24)

References (22)
  • 1
    • 0028868603 scopus 로고
    • Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary.brosis. A review of Japanese cases
    • Mizushima Y, Kobayashi M. Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary .brosis. A review of Japanese cases. Chest 1995;108:1272-1277.
    • (1995) Chest , vol.108 , pp. 1272-1277
    • Mizushima, Y.1    Kobayashi, M.2
  • 3
    • 72249100589 scopus 로고    scopus 로고
    • An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library
    • Ohyabu N, Hinou H, Matsushita T, et al. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. J Am Chem Soc 2009;131:17102-17109.
    • (2009) J Am Chem Soc , vol.131 , pp. 17102-17109
    • Ohyabu, N.1    Hinou, H.2    Matsushita, T.3
  • 4
    • 0030963799 scopus 로고    scopus 로고
    • Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin
    • Oyama T, Kohno N, Yokoyama A, et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 1997;175:379-385.
    • (1997) Lung , vol.175 , pp. 379-385
    • Oyama, T.1    Kohno, N.2    Yokoyama, A.3
  • 5
    • 0031739485 scopus 로고    scopus 로고
    • Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis
    • Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998;158: 1294-1298.
    • (1998) Am J Respir Crit Care Med , vol.158 , pp. 1294-1298
    • Takahashi, T.1    Munakata, M.2    Suzuki, I.3    Kawakami, Y.4
  • 6
    • 0033771886 scopus 로고    scopus 로고
    • KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases
    • Fukaya S, Oshima H, Kato K, et al. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases. Rheumatol Int 2000;19:223-225.
    • (2000) Rheumatol Int , vol.19 , pp. 223-225
    • Fukaya, S.1    Oshima, H.2    Kato, K.3
  • 8
    • 0034913409 scopus 로고    scopus 로고
    • Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia
    • Arai Y, Obinata K, Sato Y, et al. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia. Eur J Pediatr 2001;160: 425-429.
    • (2001) Eur J Pediatr , vol.160 , pp. 425-429
    • Arai, Y.1    Obinata, K.2    Sato, Y.3
  • 9
    • 0036469096 scopus 로고    scopus 로고
    • Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
    • Ohnshi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002;165:378-381.
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 378-381
    • Ohnshi, H.1    Yokoyama, A.2    Kondo, K.3
  • 10
    • 0346993504 scopus 로고    scopus 로고
    • Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis
    • Janssen R, Sato H, Grutters JC, et al. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 2003;124:2119-2125.
    • (2003) Chest , vol.124 , pp. 2119-2125
    • Janssen, R.1    Sato, H.2    Grutters, J.C.3
  • 11
    • 0024077916 scopus 로고
    • Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma
    • Kohno N, Akiyama M, Kyoizumi S, et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-216.
    • (1988) Jpn J Clin Oncol , vol.18 , pp. 203-216
    • Kohno, N.1    Akiyama, M.2    Kyoizumi, S.3
  • 12
    • 0003425741 scopus 로고    scopus 로고
    • Histological Typing of Lung and Pleural Tumours
    • World Health Organization. third edition. Geneva: WHO
    • World Health Organization. Histological Typing of Lung and Pleural Tumours. International Histological Classification of Tumours, third edition. Geneva: WHO; 1999.
    • (1999) International Histological Classification of Tumours
  • 13
    • 0030912190 scopus 로고    scopus 로고
    • Revisions in the international system for staging lung cancer
    • Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
    • (1997) Chest , vol.111 , Issue.6 , pp. 1710-1717
    • Mountain, C.F.1
  • 14
    • 0142151640 scopus 로고    scopus 로고
    • Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: Analyses of short-term and long-term outcomes
    • Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: Analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003;126:1141-1146.
    • (2003) J Thorac Cardiovasc Surg , vol.126 , pp. 1141-1146
    • Chiyo, M.1    Sekine, Y.2    Iwata, T.3
  • 15
    • 69249174126 scopus 로고    scopus 로고
    • Impact of interstitial lung disease on survival for patients with non-small cell lung cancer
    • Miyazaki K, Satoh H, Kurishima K, et al. Impact of interstitial lung disease on survival for patients with non-small cell lung cancer. Anticancer Res 2009;29:2671-2674.
    • (2009) Anticancer Res , vol.29 , pp. 2671-2674
    • Miyazaki, K.1    Satoh, H.2    Kurishima, K.3
  • 16
    • 57349095906 scopus 로고    scopus 로고
    • The International Epidemiology of Lung Cancer: Geographical distribution and secular trends
    • Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: Geographical distribution and secular trends. J Thorac Oncol 2008;3:819-831.
    • (2008) J Thorac Oncol , vol.3 , pp. 819-831
    • Youlden, D.R.1    Cramb, S.M.2    Baade, P.D.3
  • 17
    • 74049087802 scopus 로고    scopus 로고
    • Lung cancer: Progress in diagnosis, staging and therapy
    • Spiro SG, Tanner NT, Silvestri GA, et al. Lung cancer: Progress in diagnosis, staging and therapy. Respirology 2010;15:44-50.
    • (2010) Respirology , vol.15 , pp. 44-50
    • Spiro, S.G.1    Tanner, N.T.2    Silvestri, G.A.3
  • 18
    • 2342516124 scopus 로고    scopus 로고
    • Phenotype of regenerative epithelium in idiopathic interstitial pneumonias
    • Hinata N, Takemura T, Ikushima S, et al. Phenotype of regenerative epithelium in idiopathic interstitial pneumonias. J Med Dent Sci 2003;50:213-224.
    • (2003) J Med Dent Sci , vol.50 , pp. 213-224
    • Hinata, N.1    Takemura, T.2    Ikushima, S.3
  • 19
    • 1642534548 scopus 로고    scopus 로고
    • Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors
    • Hara R, Itami J, Komiyama T, Katoh D, Kondo T. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. Chest 2004;125:340-344.
    • (2004) Chest , vol.125 , pp. 340-344
    • Hara, R.1    Itami, J.2    Komiyama, T.3    Katoh, D.4    Kondo, T.5
  • 20
    • 33646890233 scopus 로고    scopus 로고
    • Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy
    • Matsuno Y, Satoh H, Ishikawa H, et al. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy. Med Oncol 2006;23:75-82.
    • (2006) Med Oncol , vol.23 , pp. 75-82
    • Matsuno, Y.1    Satoh, H.2    Ishikawa, H.3
  • 21
    • 33750018921 scopus 로고    scopus 로고
    • Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases
    • DOI 10.1111/j.1365-2796.2006.01704.x
    • Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 2006;260:429-434. (Pubitemid 44571130)
    • (2006) Journal of Internal Medicine , vol.260 , Issue.5 , pp. 429-434
    • Satoh, H.1    Kurishima, K.2    Ishikawa, H.3    Ohtsuka, M.4
  • 22
    • 34247477208 scopus 로고    scopus 로고
    • Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma
    • Inata J, Hattori N, Yokoyama A, et al. Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma. Int J Cancer 2007;120:2643-2649.
    • (2007) Int J Cancer , vol.120 , pp. 2643-2649
    • Inata, J.1    Hattori, N.2    Yokoyama, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.